Evidence map›Paper›PMID 19651503›Full record

ReviewCurrent opinion in immunology2009

Genetics of hypogammaglobulinemia: what do we really know?

Mary Ellen Conley

Abstract readReview
In one paragraph

Review in Current opinion in immunology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. An essential role for the ZnNature immunology · 2019
    Article
  4. Article
  5. Article
  6. Review
  7. Common Variable Immunodeficiency and Circulating TFH.Journal of immunology research · 2016
    Article
  8. Mutations in Bruton's tyrosine kinase impair IgA responses.International journal of hematology · 2015
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Mary Ellen ConleyDepartment of Pediatrics, University of Tennessee College of Medicine, Memphis, TN, USA. maryellen.conley@stjude.org

Funding

GENETIC ASPECTS OF IMMUNODEFICIENCIESR37AI025129 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CONLEY, MARY ELLEN · 1999 to 2007
$2.7M
NIAID NIH HHS R37 AI025129
6 · The paper itself

Abstract

In the past, immunodeficiencies were categorized based on clinical and laboratory findings in the affected patient. Now we are more likely to define them based on the specific gene involved. One might expect this shift to increase the precision and clarity of diagnosis but in the last few years it has become increasingly clear that identification of a mutation in a specific gene may not tell the whole story. Some gene defects may reliably result in clinical disease, others may act as susceptibility factors that are more common in patients with immunodeficiency but can also be found in otherwise healthy individuals. Distinguishing between these two types of gene defects is essential for informative genetic counseling.

Indexed as

MutationAgammaglobulinaemia Tyrosine KinaseAgammaglobulinemiaB-LymphocytesDiagnosis, DifferentialGenetic CounselingGenetic Diseases, X-LinkedGenetic Predisposition to DiseaseHumansProtein-Tyrosine KinasesAgammaglobulinaemia Tyrosine KinaseProtein-Tyrosine Kinases

Identifiers

PMID19651503
PMCPMC2761500

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.